Diabetes


MINNEAPOLIS - The University of Minnesota and the Mayo Clinic announced Tuesday they hope to raise between $250 million and $350 million for expanded research into treatments and a cure for diabetes.

SPLIT DECISION: U.S. health officials restricted access to the controversial diabetes pill Avandia Thursday, even as European regulators ordered it off the market based on heart attack risks.

U.S. health regulators dealt a major blow to the controversial diabetes pill Avandia Thursday, requiring doctors and patients to sign consent forms before starting a prescription of the drug.

European regulators ordered the diabetes drug Avandia off the market and the Food and Drug Administration placed stringent restrictions on its use in the United States, saying heart attack risks associated with the former blockbuster are too great a safety concern to continue its use for most people.

European health regulators have banned sales of the once-blockbuster diabetes drug Avandia because of evidence it raises the risk of heart attack, but doctors in the U.S.
Older News
S M T W T F S
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2010 The Gaea Times